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Purpose: To test the feasibility of using multi-scale MRI texture analysis to assess optic nerve pathology and to
investigate how visual recovery relates to the severity of acute tissue damage in the optic nerve in patients
after optic neuritis (ON).
Materials and Methods:We recruited 25 patients with acute ON. Retinal nerve ﬁber layer (RNFL) thickness; MRI
lesion length and enhancement; optic nerve area ratio; and multi-scale MRI texture analysis, a measure of
structural integrity, were used to assess tissue damage at baseline, and at 6 and 12 months. The recovery in vision
was deﬁned as the functional outcome. Eight healthy subjects were imaged for control.
Results:We identiﬁed 25 lesions in the affected eyes (9 enhanced) and 5 in the clinically non-affected eyes (none
enhanced). At baseline, we found that RNFL valueswere 20% thicker and lesion texture 14%more heterogeneous
in the affected eyes than in the non-affected eyes, and lesion texture ratio of affected to non-affected eyes was
greater in patients than in controls. In the affected eyes, visual acuity recovered signiﬁcantly over 6 (18/23
patients) and 12 months (18/21 patients) when RNFL thickness and optic nerve area ratio decreased over
time. Texture heterogeneity in the standardMRI of acute optic nerve lesionswas the onlymeasure that predicted
functional recovery after ON.
Conclusions: Tissue heterogeneitymay be a potentialmeasure of functional outcome inONpatients and advanced
analysis of the texture in standardMRI could provide insights intomechanisms of injury and recovery in patients
with similar disorders.© 2014 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
Functional recovery varies in patients with multiple sclerosis (MS)
following acute inﬂammation (Hirst et al., 2012) and is difﬁcult to pre-
dict. As an acute inﬂammatory episode affecting the optic nerve and a
frequent initial presentation of MS (Balcer, 2006), optic neuritis (ON)
is often used as a model to study the relationship between structure
and function; both can be measured independently (Jenkins et al.,
2009). The ability to predict functional recovery at symptom onset
may have potential implications in the long-term treatment of MS.
Currently whether and how optic nerve damage relates to visual re-
covery after acute ON is not fully understood. Some report that shorter
enhancing lesions in magnetic resonance imaging (MRI) (Hickmanerms of the Creative Commons
which permits non-commercial
d the original author and source
arch Building, 3330 Hospital Dr
; fax: +1 403 283 8731.
lished by Elsevier Inc. All rights reseret al., 2004a) and slower loss of retinal nerve ﬁber layer (RNFL) thick-
ness in early ON (Costello et al., 2006) correlate to better visual out-
come. But others claim that acute MRI lesions do not consistently
predict visual recovery (Hickman et al., 2004a; Kupersmith et al.,
2011), and that visual acuity at month 12 does not correlate with
acute tissue injury in ON measured by visual evoked potential, RNFL,
MRI lesion length, or diffusion tensor imaging (DTI) (Jenkins et al.,
2010).
Advanced analysis of the severity of tissue damagemay help us clar-
ify the interactions between structure and function. MRI texture analy-
sis is a quantitative approach that evaluates inter-voxel relationships in
an image and has shown great potential to detect subtle structural
changes following acute inﬂammation (Kassner and Thornhill, 2010;
Zhang, 2012). For example, using a local spatial frequency-based analy-
sis technique, polar Stockwell transform (PST), investigators found that
MRI texture analysis not only correlates with the type of pathological
damage in postmortem MS brain, but also in vivo, it differentiates
acute lesions from chronic lesions (Zhang et al., 2009) and distinguishes
acute lesions that persist from those that recover 5 to 8 months earlier
than visual perception in MS (Zhang et al., 2011). Using a similarved.
303Y. Zhang et al. / NeuroImage: Clinical 4 (2014) 302–307approach, another group found that acute lesion texture in baselineMRI
predicted disability progression over 2 years in MS patients (Loizou
et al., 2010).
Our goal of this study was to evaluate prospectively how visual re-
covery relates to the severity of acute tissue damage in the optic nerve
assessed by PST texture analysis, and other structural measures includ-
ing MRI enhancing and non-enhancing lesion length, optic nerve area,
and RNFL thickness assessed by optical coherence tomography (OCT).
2. Material and methods
2.1. Participants
Twenty-ﬁve patients with acute ON in the context of relapsing–
remitting MS (Polman et al., 2005) or clinically isolated syndrome
(CIS) were recruited within two weeks of symptom onset. Participants
with any other neurological or ophthalmologic diseases were excluded.
Ophthalmic, MRI, and OCT assessmentswere performed at baseline, and
at 6 and 12 months thereafter. Eight age- and gender-matched healthy
subjects were imaged for control. This study was approved by the Insti-
tutional Health Research Ethics Board, and written informed consent
was obtained from each participant. All clinical investigations were
conducted according to the Declaration of Helsinski.
2.2. Ophthalmic Assessment
High-contrast visual acuity was assessed using the Early Treatment
Diabetic Retinopathy Study (ETDRS) chart at 4 m. Participants wore
contact lenses or glasses if applicable and were instructed to read the
letters by each eye. The number of letters identiﬁed out of 70 was con-
sidered the best-corrected visual acuity, recorded as logMAR (logarithm
of theminimumangle of resolution) (Ferris et al., 1982). Higher logMAR
values represent poorer vision, and the worst vision score of 1.5 was
assigned to the participants who recognized no letters but perceived
hand motion, light perception, or neither.
2.3. OCT Testing
Peripapillary images of RNFL were acquired using OCT (Stratus
version 3; Carl Zeiss Meditec, Dublin, USA). After mydriasis with 1%
tropicamide, three retinal scanswere conducted circularly with a diam-
eter of 3.4 mm, from which the RNFL thickness at 256 points of the
circumference was recorded per scan. The mean RNFL value in each
eye was obtained using an automatic algorithm as reported previously
(Costello et al., 2006).
2.4. MRI Protocol
All participants were imaged within 4 weeks of ON at a 3 T scanner
(GE Signa, WI, USA) using optimized optic nerve protocols. These
included: coronal short tau inversion recovery (STIR) sequence
[repetition time (TR) = 4500 ms, echo time (TE) = 46 ms, inver-
sion recovery = 195 ms]; coronal spin echo T1-weighted pre- and 5-
min post-contrast fat-saturated sequences [TR = 500 ms, TE =
15 ms], with identical settings for ﬁeld of view (18 × 18 cm2), matrix
size (512 × 512), and slice thickness (4 mm). Participants were
instructed to limit movement and close eyes during imaging to mini-
mize artifacts. Control subjects were imaged one time only without
contrast.
2.5. Anatomical MRI Analysis
Lesion length was evaluated on the coronal STIR images as slice
thickness multiplied by the number of slices showing signal abnormal-
ity. Also in STIRMRI, cross-sectional area of the optic nerve was quanti-
ﬁed using a semi-automatic region-growing algorithm (Osirix for Mac),and the averaged area from 3 consecutive slices central, anterior, and
posterior to the lesion was used as the ﬁnal value for the optic nerve.
In the non-ON or control eyes, optic nerve area was obtained by aver-
aging areas from 3 equivalentMRI locations of the optic nerve as those
set for the ON eyes. Then, the ratio of affected (ON) to clinically non-
affected (non-ON) optic nerve area in patients, right to left optic
nerve area ratio in controls, was computed to account for inter-
subject variability, a suggested approach in optic nerve studies
(Henderson et al., 2010; Klistorner et al., 2008). Gadolinium-
enhancing activity was evaluated on the fat-saturated post-contrast
T1 MRI in all but 2 participants who declined contrast injection, by
twoMRI neuroradiologists (YZ & JNS, both with over 10 years of expe-
rience). The entire image analysis for one participant took approxi-
mately half an hour, including the semi-automatic measurements
(YZ, 11 years of experience).2.6. Multi-scale MRI Texture Analysis
The coronal STIR image showing the largest cross-sectional area of
the lesion was used for texture analysis. This MRI contrast had the abil-
ity to capture the inclusive changes raised by ON lesions that also lasted
longer in this imaging sequence. As reported previously (Zhang et al.,
2009; Zhu et al., 2004), fast Fourier transform was initially conducted
to obtain the total frequency content in the image and then for each
frequency, its spectral amplitude at individual voxel locations was
determined by performing inverse Fourier transform. Eventually, a
multi-scale texture spectrum at each voxel was derived ranging from
coarse to ﬁne texture (Fig. 1). Each of these steps can be done using
open source software such as ImageJ (NIH, USA). In this study, the anal-
ysis was centered at the optic nerves with an area of 300 × 300 voxels,
and a high spectral resolution of 0.009 hertz/mm was achieved for
detailed structural evaluation.
Based on the dissimilarity in texture spectra between lesion and
reference voxels in the white matter, texture heterogeneity maps
were calculated (see Fig. 1). Thiswas based on the theory of dot product
in mathematics (Spiegel et al., 2009), which computed the phase angle
between texture spectra that were treated as multi-dimension vectors.
As the distribution of texture spectrum reﬂects the local pattern of
image voxels that in turn relates to the organization of tissue micro-
structure, greater texture heterogeneity represents greater loss of tissue
regularity. Lesion texture of the optic nerve was extracted from the
heterogeneity maps by applying corresponding lesion masks that
were derived from the measurement of optic nerve area in STIR MRI.
Similarly, control nerve texture was obtained based on the masks of
control nerve area that corresponded to the center of ON lesions.
Again, the ratio of ON to non-ON nerve texture (right to left in controls)
was used to compare between cohorts and timepoints. The reliability of
our assessingmethodswas tested using the left and right eyes in control
subjects.2.7. Statistical Analysis
Two-variable comparisons were done using Student's t-test, and
mixed-effect modeling was used to explore longitudinal changes. Func-
tional outcome was deﬁned as the recovery in logMAR over time from
baseline. The relationship between baseline measures and functional
outcomewas assessed,ﬁrstly by univariate regression, and then bymul-
tiple regression on all variables showing importance (p ≤ 0.1) individ-
ually, using age and non-ON eye visual acuity as covariates. Finally, all
baseline structural measures were included in the model to identify
independent predictors of functional outcome. All analyses were con-
ducted using Stata 12 (StataCorp, College Station, TX, USA); p ≤ 0.05
was set as signiﬁcance. Subjects with incomplete datasets were exclud-
ed from analyses.
Fig. 1. A demonstration of our texture analysis method. In the coronal STIRMR image (A), two reference regions (squares, 10 × 10 voxel each) were chosen symmetrically in the normal
appearing white matter (NAWM) of bi-hemispheres. Using the polar Stockwell transform, multi-scale texture spectra of the NAWM (B) and the whole image (C) were computed, one
spectrumper voxel that forms a spectral stack from all voxels in C. Calculating the spectral difference between B and C gives rise to the texture heterogeneitymap for image A (D),wherein
the texture of optic nerves was highlighted (irregular outlines in D) by the regions of interest segmented from the anatomical MRI (small images below D).
Table 1
Demographic and visual outcomes of patients with acute optic neuritis.
Patient ID ON Diagnosis Visual recovery in logMAR
6 M vs baseline 12 M vs baseline
1 OD MS −0.5 −0.4
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3.1. Demographic and Clinical Characteristics
Of the 25 participants, 16 of themhadON in the left eye (OS), 9 in the
right eye (OD), and 4 in the fellow eye prior to (3 subjects) or during the
study (1 subject). The mean (range) age of all subjects was 33 (22–50)
years; EDSS score was 1.2 (0–3) and disease duration was 4 (0–13)
years in MS subjects. Twenty-three participants completed month-6
follow-up and 21 completed month-12 follow-up. Two subjects (1
MS; 1 CIS) received high-dose corticosteroid to treat acute ON; 6 MS
subjects were using disease-modifying therapies (3 on glatiramer
acetate; 3 on interferon beta); and the degree of visual recovery was
not different between MS and CIS patients (Table 1).2 OS CIS 0 0
3 OS CIS −1.6 −1.7
4 OD CIS −0.2 −0.3
5 OD MS 0 −0.1
6 OS MS −0.3 −0.3
7 OD CIS 0.1 −0.1
8 OS CIS −1.4 −1.4
9 OS MS −1.4 −1.1
10 OS* MS −0.7 −0.8
11 OD* MS −1.6 −1.5
12 OS MS −0.1 −0.3
13 OS CIS −0.1 03.2. Lesion Characteristics
There were 22 focal hyperintense lesions in the ON eyes (11 MS; 11
CIS) and 5 in the non-ON eyes of MS patients, and there was subtle sig-
nal abnormality in the other 3 ON eyes (2 MS; 1 CIS). Nine focal lesions
enhanced, all in the ON eyes (5MS; 4 CIS). No lesions were identiﬁed in
the non-ON eyes of CIS patients, and no abnormalitywas found in any of
the control subjects.14 OD* MS −0.7 −0.7
15 OS CIS −0.2 −0.2
16 OS CIS −0.1 0
17 OS CIS −0.4 −0.2
18 OS* MS −0.5 −0.5
19 OD MS −0.1 −0.1
20 OS MS −0.8 −0.8
21 OD MS −0.9 −0.8
Abbreviations: ON: optic neuritis; OD: right eye; OS: left eye; MS: multiple sclerosis;
CIS: clinically isolated syndrome; LogMAR: logarithm of the minimum angle of
resolution; M: month.
Note: All the listed patients here had complete datasets; those who had non-ON eye
affected* prior to (# 10, 11, and 14) or during (#18) the study were excluded from ratio
calculations.3.3. Baseline Structural and Functional Outcomes
Within subjects, visual acuitywas 0.50-unitworse (p b 0.001); RNFL
was 20% thicker (p b 0.001); and MRI texture was 14% (p = 0.10)
coarser in the ON eyes than in the non-ON eyes (Fig. 2). In patients,
optic nerve texture ratio was 24% greater (p = 0.04) and optic nerve
area ratio was 7% larger (p = 0.39) than in controls. No difference
was detected in any measurements between MS and CIS participants
(Table 2), or between two eyes of control subjects includingMRI texture
analysis (p = 0.28).3.4. Longitudinal Structural and Functional Outcomes
Compared to baseline, visual acuity improved in most subjects over
time (p b 0.01), and no subject experienced visual worsening at
one year. In particular, 18/23 (78%) participants showed recovery over
6 months, and 18/21 (86%) over 12 months; at both follow-ups, visual
difference between ON and non-ON eyes was also resolved (p = 0.91
Fig. 2. BaselineMR images from two participants with acute optic neuritis showing different degrees of texture heterogeneity and visual recovery. The ﬁrst subject (left column) shows a
hyperintense lesion on STIRMRI (A1) in the left eye (arrows), with increasedMRI texture heterogeneity (0.50 unit, yellow-red in B1) compared to the other eye (0.39 unit, green at arrow
head in B1), and 12-month visual recovery of 0.8 logMAR unit. The other subject (right column) shows subtle abnormality in the right eye (arrow, A2), but with greater heterogeneity in
MRI texture at baseline (0.62 unit, yellow–red in B2) and less visual recovery (0.1 logMAR unit). The control eye texture of this subject was 0.51 unit (green–yellow, arrow head in B2).
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(p = 0.20) but it followed a similar recovery pattern to that of visual
function. RNFL thickness decreased at month 6 (p b 0.01) yet did not
change signiﬁcantly (3%) between 6 and 12 months in ON eyes and
remained stable in non-ON eyes. Over 12 months, there was a 14%Table 2
Baseline measures in optic neuritis eyes of patients with multiple sclerosis or clinically
isolated syndrome and in control eyes.
Outcome Mean (stderr) p value
MS (n = 12) LogMAR 0.59 (0.15) b0.001
RNFL (micron) 122.80 (9.20) 0.03
Texture value (a.u) 0.48 (0.03) 0.27
Texture ratio 1.19 (0.10) N/A
Area ratio 1.14 (0.05) N/A
T2 lesion length (mm) 12.09 (1.26) 0.30
Gd lesion length (mm) 9.17 (0.86) N/A
CIS (n = 9)
LogMAR 0.46 (0.20) 0.03
RNFL (micron) 121.89 (6.36) 0.01
Texture value (a.u) 0.50 (0.05) 0.07
Texture ratio 1.19 (0.10) N/A
Area ratio 1.08 (0.05) N/A
T2 lesion length (mm) 15.38 (2.00) N/A
Gd lesion length (mm) 9.00 (0.94) N/A
Control (n = 8)
Texture ratio 0.93 (0.05) 0.04*
Area ratio 1.05 (0.08) 0.39*
Abbreviations: ON: optic neuritis; MS: multiple sclerosis; CIS: clinically isolated
syndrome; Gd: gadolinium; RNFL: retinal nerve ﬁber layer; logMAR: logarithm of the
minimum angle of resolution; and a.u: arbitrary unit.
Note: P values with * indicate differences between ON patients and controls, otherwise
between ON and non-ON eyes of the patients. Any subjects who had non-ON eye affected
previously were excluded from texture and area ratio calculations.reduction in the optic nerve area ratio (p = 0.03) in ON patients, but
no change in STIR lesion length (p = 0.99; Table 3).
3.5. Baseline Lesion Texture Heterogeneity Predicted Visual Recovery
After ON
Baseline lesion texture independently correlated with the extent of
visual recovery over 6 (r = 0.49, p = 0.03) and 12 months (r = 0.50,
p = 0.02) in ON eyes (Fig. 3). Speciﬁcally, one unit decrease in lesion
texture was related to 2 unit improvement in visual acuity (approxi-
mately 2 lines on the eye chart). No other MRI or ophthalmic variables
at baseline correlated with visual recovery over 6 or 12 months, either
individually or in combination with adjustment for age and non-ON
eye visual acuity (Table 4). No month 6 variable correlated with visual
recovery between 6 and 12 months.
4. Discussion
In this prospective study, we demonstrate that the severity of acute
tissue damage in the optic nerve, as determined by MRI texture hetero-
geneity, predicts the degree of visual recovery inMS and CIS patients. As
a potentially new measure of subtle pathological changes, PST texture
heterogeneity outperforms several recognized structural metrics
including RNFL, optic nerve area, and lesion length and activity.
PST texture analysis measures the regularity of tissue structure
reﬂected by the patterns of image intensity but determined by the bio-
physical property of tissue microstructure. Consequently, pathological
processes that involve remodeling of biological structure should lead
to changes in the distribution pattern of MRI signal intensity and
hence MRI texture (Yu et al., 2004). What makes it different from
manyother texture analysismethods is the ability of PST to detect tissue
changes in both ﬁne and coarse texture spectrum (ranging from sub-
Table 3
Longitudinal outcomes in the structure and function of optic neuritis eyes.
Baseline 6 months 12 months 12-month change
Mean (Stderr) Mean (Stderr) Mean (Stderr) p value
ON logMAR 0.53 (0.11) −0.01 (0.03) −0.01 (0.04) b0.01
Texture ratio 1.15 (0.08) 1.12 (0.04) 1.17 (0.05) NS
RNFL (micron) 120.95 (5.65) 92.52 (3.56) 86.50 (3.69) b0.01
Area ratio 1.11 (0.04) 1.03 (0.03) 0.99 (0.04) 0.03
T2 lesion length (mm) 13.21 (1.15) 13.17 (1.08) 13.29 (1.10) NS
Gd lesion length (mm) 10.29 (0.41) 8* / N/A
Non-ON logMAR −0.01 (0.03) −0.02 (0.03) −0.04 (0.04) NS
Abbreviations: ON: optic neuritis; Gd: gadolinium; RNFL: retinal nerve ﬁber layer; logMAR: logarithmof theminimum angle of resolution; Stderr: standard error; NS: not signiﬁcant; N/A:
not applicable.
Note: Measures in bold reﬂect signiﬁcant differences as compared to baseline; p values indicate levels of difference between month 12 and baseline measures. *: one lesion only.
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sensitivity. Indeed, postmortem analysis in T2 MRI conﬁrms that PST
texture heterogeneity strongly correlates with the density of myelin
stained by luxol fast blue, and at a lesser extent, the axonal density
and inﬂammatory in MS brain (Zhang et al., 2013). Thus, in the current
study, greater texture heterogeneity indicates more severe pathological
damage in the optic nerve that relates to less recovery in vision.
Except MRI texture heterogeneity, we did not ﬁnd signiﬁcant corre-
lations between other structural measures and visual recovery in this
study. Post-acutemeasures of RNFL thickness have shown robust corre-
lations with various visual outcomes in ON and MS patients (Cettomai
et al., 2010; Costello et al., 2006; Fisher et al., 2006; Talman et al.,
2010; Trip et al., 2005; Villoslada et al., 2012). Acutely, however, in-
creased RNFL values, owing to optic disc swelling, may not correlate
with the severity of tissue damage or visual dysfunction (Kupersmith
et al., 2011). Similarly, acute enlargement of optic nerve area represents
transient edema of the nerve in MRI (Hickman et al., 2004b). Although
lesion length and enhancing activity both reﬂect the burden of inﬂam-
mation, their correlation with clinical outcome is inconsistent in ON
patients (Hickman et al., 2004a; Kupersmith et al., 2011).
We found that dominant recovery in vision occurred within
6 months of ON in our patients, consistent with prior observations
(Brusa et al., 2001; Henderson et al., 2011; Smith et al., 2011). In thisFig. 3.BaselineMRI texture heterogeneity in the affected eyes of the optic neuritis patients
predicts visual recovery over 6 and 12 months. Larger intercept in logMAR indicates
greater change: below zero means recovery; above zero means worsening; and zero
represents no change.study, we aimed at the ON patients commonly seen at the daily clinic,
in the context of either MS or CIS, to represent a general sample.
Given a baseline logMAR of 0.53 in this group, regaining normal vision
at month 6 suggests profound visual recovery. Over this period, both
RNFL thickness and optical nerve area reduced signiﬁcantly. Reportedly
the rapid early decline in these metrics indicates resolution of acute in-
ﬂammation, but not tissue atrophy (Hickman et al., 2004b; Kupersmith
et al., 2011). And this recovering process, together with active
remyelination evidenced to occur between 3 and 6 months of ON
(Brusa et al., 2001; Klistorner et al., 2010), likely promotes visual
recovery.
Chronic demyelination and axonal loss (Klistorner et al., 2008) how-
ever often overshadow the weakening process of remyelination (Brusa
et al., 2001) over time, which may ultimately compromise functional
repair (Brusa et al., 1999, 2001) and has also contributed to the persis-
tence of lesion length and texture heterogeneity in this cohort. Addi-
tionally, there was up to a 30-day delay for the patients to have MRI
after onset. Arguably, the most active phases of inﬂammation identiﬁed
as enhancing lesions in the ON have been missed in some patients,
which likely also contributed to the insigniﬁcant outcomes. Indeed, pre-
vious analysis found signiﬁcant texture changes in only 12 acute brain
lesions in the T2 MRI of MS patients (Zhang et al., 2009). In the future,
we seek to conﬁrm the current results in large-sample studies and to
verify the relationship between acute inﬂammation, tissue heterogene-
ity, and functional recovery.
There are few structure integrity studies in the literature, mostly
using DTI; and often, with disparate results. Some researchers demon-
strate the potential of axial diffusivity 3 to 6 months after ON
(Naismith et al., 2009, 2012)whereas others support baseline functional
MRI but not DTI (Jenkins et al., 2010) to predict visual function. While
the role of neuroplasticity is critical, the lack of difference between MS
and CIS outcomes in this study supports the signiﬁcance of the severity
of acute tissue damage to functional repair. By analyzing the local pat-
tern of signal intensity to infer tissue integrity, PST texture analysis is
conceptually different from DTI, an advanced image acquisition-basedTable 4
The relationship between baseline measurements and visual recovery over 6 and
12 months in the optic neuritis eyes.
6-month recovery 12-month recovery
r p r p
Texture (a.u) 0.49 0.03 0.50 0.02
RNFL (micron) 0.05 0.82 0.05 0.85
Nerve Area ratio −0.21 0.36 −0.18 0.46
T2 lesion length (mm) −0.16 0.51 −0.20 0.44
Gd lesion length (mm) 0.02 0.95 0.03 0.92
Age (year) 0.03 0.91 0.11 0.64
Disease duration (year) −0.06 0.81 −0.03 0.89
Non-ON logMAR −0.09 0.75 −0.05 0.82
Abbreviations: ON: optic neuritis; Gd: gadolinium; RNFL: retinal nerve ﬁber layer;
logMAR: logarithm of the minimum angle of resolution; a.u: arbitrary unit.
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molecules in a tissue. Using clinical MRI that is easy to standardize and
less susceptible to the small size andmobility of optic nerve, our results
suggest that PST-measured structure heterogeneity may become a
useful index of functional recovery in routine patient care.
We note some limitations in this study. First, our sample size is rath-
er small limiting broad conclusions. In addition, we focused on the optic
nerve, not other levels of visual hierarchy, yet this approach provided us
a unique opportunity to examine structure and function independently.
In texture analysis, we targeted the epicenter of optic nerve lesions.
While this excluded peripheral pathology, our focus on the lesion core
is consistent with the hallmark of MS pathology, multi-focal plaques
(Lassmann et al., 1994). Further, we used high-contrast letter acuity
to assess visual function. This conventional test of spatial visual percep-
tion has limited sensitivity (Fisher et al., 2006) and may have under-
estimated the visual deﬁcit in our patients, although this measure
shows promise in several studies of ON (Jenkins et al., 2010; Kolbe
et al., 2009) and allowed us to demonstrate proof-of-concept evidence
in this study. In future prospective investigations, we aim to validate
our data by comparing with DTI and including comprehensive assess-
ments of vision such as low-contrast letter acuity, contrast sensitivity,
color vision, and mean deviation.
5. Conclusions
In this prospective study, we show that greater structural heteroge-
neity predicts less functional recovery in patients with acute ON. As an
image post-processing technique, PST texture analysis is embeddable
to standard MRI. By providing quantitative metrics of tissue injury and
functional repair in a reasonable time window, this method may help
enhance our patient care abilities in both diagnosis and treatment. Be-
sides MS and CIS, this approach should beneﬁt the patients with several
other similar disorders.
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